Position in PSNL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,966,393
+$1,618,859 QoQ
Shares Held
308,696
+413.4% QoQ
Ownership
0.289%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PSNL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $727,123,354 across 18 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
449,628 | $225,425,494 | |
| 2 | DHR |
Danaher Corp /De/
|
759,207 | $144,613,749 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
700,425 | $135,336,117 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
54,686 | $69,861,911 | |
| 5 | DGX |
Quest Diagnostics Inc
|
275,371 | $58,364,883 | |
| 6 | WAT |
Waters Corp /De/
|
138,443 | $51,921,662 | |
| 7 | GH |
Guardant Health, Inc.
|
124,368 | $18,658,930 | |
| 8 | RVTY |
Revvity, Inc.
|
63,056 | $7,015,610 |
All Filings in PSNL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,966,393 | 308,696 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $347,534 | 60,127 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $77,097 | 65,895 | Shares | Sole | 2024-08-14 | |
| 2023-06-30 | $201,833 | 107,358 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,772,723 | 1,004,610 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||